PRP in Early Osteoarthritis: Preserving Joint Health Through Regeneration

Osteoarthritis represents one of the most prevalent orthopedic conditions worldwide. PRP therapy offers a regenerative strategy aimed at preserving joint structure and delaying disease progression rather than simply alleviating symptoms.

PRP improves joint homeostasis by enhancing synovial lubrication, reducing catabolic inflammation, and supporting cartilage cell viability. Patients receiving PRP often report sustained pain reduction and improved joint function compared to hyaluronic acid or corticosteroid injections.

The success of PRP in osteoarthritis depends heavily on product quality, platelet concentration, and injection accuracy. CE Marked Class IIb PRP systems provide orthopedic practitioners with confidence in procedural safety and consistency.

As regenerative orthopedics continues to evolve, PRP remains a foundational therapy for joint preservation strategies worldwide.